Management of Neoplastic Polyps in Inflammatory Bowel Disease
Open Access
- 1 July 2003
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 9 (4) , 260-266
- https://doi.org/10.1097/00054725-200307000-00006
Abstract
Dysplasia-associated lesions or masses (DALMs) are a heterogeneous population of lesions with different endoscopic and morphologic features. Non-adenoma-like DALMs should be removed via colectomy. Adenoma-like DALMs that occur outside areas of colitis can be treated like sporadic adenomas and removed by polypectomy. Recent data suggest that adenoma-like DALMs located within areas of colitis should be removed by polypectomy with complete excision and multiple biopsies of the site. As long as there is no flat dysplasia or adenocarcinoma elsewhere in the colon, a colectomy is not required. However, this group of patients requires increased colonoscopic surveillance.Keywords
This publication has 36 references indexed in Scilit:
- Cancer in inflammatory bowel diseaseGastroenterology Clinics of North America, 2002
- Cancer risk in patients with inflammatory bowel diseaseCancer, 2001
- Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years.Gut, 1990
- Hazard rates for dysplasia and cancer in ulcerative colitisDigestive Diseases and Sciences, 1989
- Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.Gut, 1988
- The Risk of Colorectal Cancer in Ulcerative Colitis: An Epidemiologic StudyScandinavian Journal of Gastroenterology, 1986
- Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study.Gut, 1986
- Incidence of colorectal cancer in proctocolitis: a retrospective study of 959 cases over 40 years.Gut, 1985
- Cancer Risk in Extensive Ulcerative ColitisAnnals of Surgery, 1978
- The development of carcinoma of the large intestine in ulcerative colitisBritish Journal of Surgery, 1959